Evidence map›Paper›PMID 41318463›Full record

ArticleCell communication and signaling : CCS2025

Bacterial exopolysaccharides mediate activation of flavin-containing monooxygenase 2 to extend lifespan in Caenorhabditis elegans.

Stefan Jakovljević, Dušan Radojević, Svetlana Soković Bajić, Emilija Brdarić, Hristina Mitrović, Jelena Đokić, Linda Baumann, Aleksandra Trifunovic, Nataša Golić, Miroslav Dinić

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stefan JakovljevićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Dušan RadojevićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Svetlana Soković BajićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Emilija BrdarićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Hristina MitrovićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Jelena ĐokićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Linda BaumannInstitute for Mitochondrial Diseases and Ageing, Medical Faculty, University of Cologne, Cologne, Germany.
Aleksandra TrifunovicInstitute for Mitochondrial Diseases and Ageing, Medical Faculty, University of Cologne, Cologne, Germany.
Nataša GolićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia.
Miroslav DinićGroup for Probiotics and Microbiota-Host Interaction, Department of Microbiology and Plant Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade, Serbia. miroslav.dinic@imgge.bg.ac.rs.

Funding

Center for Leadership Development Start Up for Science grantDeutsche Forschungsgemeinschaft SFB1218 (Project No. 269925409)Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja 451-03-136/2025-03/200042
6 · The paper itself

Abstract

The gut microbiota plays a pivotal role in modulating host physiology and longevity through the production of microbial-derived molecules. Among these, bacterial exopolysaccharides (EPS) represent a structurally diverse group of surface polysaccharides with emerging roles in regulating host well-being. Here, we investigated the role of Lactobacillus strains with the capability to produce EPS, using Caenorhabditis elegans as a model organism. Results revealed significant lifespan extension in worms fed with EPS-producing bacteria, accompanied by improved health-span markers such as enhanced pharyngeal pumping and reduced lipofuscin accumulation. Transcriptomic profiling identified robust upregulation of the host detoxification and immune defense pathways, highlighting the flavin-containing monooxygenase gene fmo-2, as one of the major mediators of longevity and stress resistance triggered by EPS-producing lactobacilli. The effect was confirmed using fmo-2p::GFP reporter animals and was abrogated in fmo-2, hlh-30, and nhr-49 mutant backgrounds. Mechanistically, we demonstrated that EPS acts through a conserved transcriptional network that primarily relies on the activation of nhr-49/PPAR-α, with purified EPS being sufficient to activate fmo-2 expression. Our findings reveal that bacterial EPS activates host xenobiotic pathways to modulate aging, positioning it as a potential tool for microbiota-based longevity interventions. These insights show how microbial products can modulate fundamental biological processes across species, opening new strategies for age-related health interventions.

Indexed as

Caenorhabditis elegansCaenorhabditis elegans ProteinsLongevityOxygenasesPolysaccharides, BacterialAnimalsCaenorhabditis elegans Proteinsdimethylaniline monooxygenase (N-oxide forming)OxygenasesPolysaccharides, BacterialAgingCaenorhabditis elegansExopolysaccharidesFMO-2ProbioticsStress resistance

Identifiers

PMID41318463
PMCPMC12781332

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.